Bnp Paribas Arbitrage Sa Holds Holding in Tenet Healthcare (THC); West Oak Capital Decreased Lam Research (LRCX) Position as Shares Rose

Tenet Healthcare Corporation (NYSE:THC) Logo

West Oak Capital Llc decreased its stake in Lam Research Corporation (LRCX) by 22.73% based on its latest 2018Q4 regulatory filing with the SEC. West Oak Capital Llc sold 125 shares as the company’s stock rose 15.56% with the market. The institutional investor held 425 shares of the industrial machinery and components company at the end of 2018Q4, valued at $57.87M, down from 550 at the end of the previous reported quarter. West Oak Capital Llc who had been investing in Lam Research Corporation for a number of months, seems to be less bullish one the $26.52B market cap company. The stock decreased 2.24% or $3.99 during the last trading session, reaching $173.78. About 2.22 million shares traded. Lam Research Corporation (NASDAQ:LRCX) has declined 6.47% since March 5, 2018 and is downtrending. It has underperformed by 10.84% the SP500. Some Historical LRCX News: 17/04/2018 – LAM RESEARCH 3Q REV. $2.89B, EST. $2.86B; 06/03/2018 – Lam Research Corp Announces Cap Return Program; 17/04/2018 – LAM RESEARCH CORP LRCX.O QUARTERLY NON-GAAP SHR $4.79; 17/04/2018 – Lam Research 3Q Rev $2.89B; 17/04/2018 – The analysis identified several other names with similarly optimistic analyst expectations, including Caterpillar and three chipmakers: Advanced Micro Devices, Lam Research and Cypress Semiconductor; 17/04/2018 – LAM RESEARCH CORP SEES FOR JUNE 2018 QTR, U.S. GAAP SHIPMENTS $3.000 BLN +/- $150 MLN; 21/05/2018 – Lam Research Presenting at Bank of America Conference Jun 6; 30/04/2018 – Alger Capital Appreciation Institutional Adds Lam Research; 14/05/2018 – Iconiq Adds Lam Research, Exits Tempur Sealy: 13F; 06/03/2018 – LAM RESEARCH CORP – ADDITIONAL $2 BLN SHARE REPURCHASE AUTHORIZATION FOR A TOTAL OF $4 BLN AUTHORIZED SINCE NOVEMBER 2017

Bnp Paribas Arbitrage Sa increased its stake in

Read more at: